Micrus Endovascular (NASDAQ: MEND) is a medical device company formed in June 1996 with its corporate headquarters in San Jose, California. Micrus Endovascular manufactures and markets both implantable and disposable medical devices used in the treatment of cerebral vascular diseases. Our products are used by interventional neuroradiologists and neurosurgeons primarily to treat cerebral aneurysms in the brain responsible for hemorrhagic stroke, a significant cause of death in the United States. The Micrus product line is an endovascular system that enables a physician to gain access to the brain in a minimally invasive manner through the vessels of the circulatory system. We believe our products provide a safe and reliable alternative to more invasive neurosurgical procedures for treating aneurysms.


Date Type Amount Investors Valuation
06/03/03 Series D 8.2M Aventic AG, Dresdner Kleinwort Capital, HBM Bioventures, PolyTechnos Venture-Partners, The MedFocus Fund, William Harris Investors, NMT New Medical Technologies Unknown


Robert Stern (President/COO)

Fred Holubow (Board Member)

Francis Shammo (Board Member)

Michael Crompton (VP Regulatory, Clinical Affairs & Quality)

View more details about all 17 people at Micrus Endovascular